At a glance
- What the study gets you
- Health checks and monitoring — no treatment given
- Type of study
- Observational (no treatment given)
- Time in hospital
- In-person visits at study sites — visit count not specified by the sponsor
- Drug or intervention
- Not specified by the sponsor
- How long the study runs
- Study runs about 35 months (dates as stated)
- About the drug or intervention
- Not specified by the sponsor
- Patient visit burden
- Not specified by the sponsor
In plain English
This study looks at partial breast reconstruction using a chest wall perforator flap (CWPF), a type of surgery, in people being treated for breast cancer. It is run by Cambridge University Hospitals NHS Foundation Trust.
Who can take part
- People having partial breast reconstruction with a chest wall perforator flap (CWPF) for primary breast cancer
- People having delayed surgery to correct a change in breast shape after earlier breast-conserving surgery (BCS)
- Each surgeon must have carried out at least 10 CWPF operations, and each hospital centre expects to do at least 10 per year
Who may not be able to
- People having breast-conserving surgery that moves tissue within the breast (volume displacement)
- People having a mastectomy, with or without immediate breast reconstruction
What taking part involves
- • Surgery to partly rebuild the breast using a chest wall perforator flap (CWPF)
Time commitment: Not stated — ask the trial team about visits, how long the study lasts, and what taking part involves.
Plain-English summary (AI-generated) from registry data. Not eligibility advice — only the trial team can confirm whether you can take part. Use the eligibility checker to see how your health profile matches this trial.
- Type of study
- Observing health over time
- Ages
- 18 Years and over
- Who
- Female
- Number of participants
- 1,001
- Started
- 2023-06-01
- Last checked
- 2024-12
Plain English Summary
What is this study?
- • Testing a new treatment for breast cancer early stage breast cancer (stage 1-3)
- • Clinical study - 1,001 participants
- • The goal of this observational study is to ascertain the outcomes following partial breast reconstruction using chest wall perforator flaps after breast conservation surgery
Who can take part?
- • Ages 18 Years and over
- • Diagnosed with breast cancer early stage breast cancer (stage 1-3)
- • Female only
Where?
- • Cambridge - Cambridge University Hospitals NHS Trust
This is a simplified summary. Always discuss with your doctor before making any decisions.
About This Trial
The goal of this observational study is to ascertain the outcomes following partial breast reconstruction using chest wall perforator flaps after breast conservation surgery.
More detail
The Main Outcomes and Measures are: A) Patient Demographics and Tumour characteristics 1. Patient demographics: age, body mass index (BMI), comorbidities 2. Preoperative tumour characteristics and location influencing surgical planning B) Treatment characteristics 1. Surgical: operative data, including flap types and distribution 2. Oncological: systemic therapies (adjuvant and neoadjuvant), radiotherapy
How this trial compares with your answers
Answer 2 more questions to improve match
What we know so far
Still need:
- • Tell us your age for better matching
- • Tell us your sex for better matching
Preliminary match based on your answers. Full eligibility requires on-site assessment including medical history, physical exam, and lab tests. This does not guarantee enrolment.
Eligibility at a Glance
Key info
- Age: 18 Years and over
- Who can join: Female only
What the study is looking for
- ✓Patients undergoing partial breast reconstruction using CWPF for primary breast cancer
- ✓Delayed correction of breast deformity following previous BCS
- ✓Each surgeon is to have performed a minimum of 10 CWPFs
- ✓Each centre anticipates completing a minimum of 10/year
Who cannot take part
- ✗Patients undergoing volume displacement BCS
- ✗Patients undergoing mastectomy +/- immediate breast reconstruction
See the full criteria
Where Is This Study? (1 UK site)
Cambridge University Hospitals NHS Trust
Cambridge CB2 0QQ, United Kingdom
How to Get in Touch
Amit Agrawal, DM, FRCS
Sponsor contactCONTACT